基本信息
views: 4
Career Trajectory
Bio
Ganesan is co-founder of the biotech company Karus Therapeutics and Chair of the EU COST Action CM1406, 'Epigenetic Chemical Biology'. He sits on the IUPAC Subcommittee for Medicinal Chemistry and Drug Development and the Royal Society of Chemistry's Bioorganic & Medicinal Chemistry Sector committee.
Ganesan's research centres around chemical biology, medicinal chemistry and organic synthesis with an emphasis on biologically active natural products and epigenetics.
Research Interests
Papers共 189 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Anna Claudia Silva,Daniel Clemente de Moraes, Denilson Costa do Carmo, Giselle Cristina Casaes Gomes,A. Ganesan,Rosangela Sabbatini Capella Lopes,Antonio Ferreira-Pereira,Claudio Cerqueira Lopes
JOURNAL OF FUNGIno. 7 (2023): 758-758
Muhammad Nadeem-Ul-Haque, Anila Bashir, Humira Karim,Sadiq Noor Khan,Zafar Ali Shah,Almas Jabeen,Shaista Qayyum,A Ganesan,M Iqbal Choudhary,Farzana Shaheen
Medical Epigeneticspp.885-899, (2021)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn